Should all patients with node-negative breast cancer receive adjuvant therapy? Identifying additional subsets of low-risk patients who are highly curable by surgery alone
- 1 October 1991
- Vol. 68 (7) , 1482-1494
- https://doi.org/10.1002/1097-0142(19911001)68:7<1482::aid-cncr2820680704>3.0.co;2-j
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The Importance of DNA Flow Cytometry in Node-Negative Breast CancerArchives of Surgery, 1990
- Validity of the clinical alert on breast cancerThe American Journal of Surgery, 1990
- Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- Tumour DNA ploidy as an independent prognostic factor in breast cancerBritish Journal of Cancer, 1987
- Tumour aneuploidy, prognostic parameters and survival in primary breast cancerBritish Journal of Cancer, 1987
- Cell Growth, Tissue Neogenesis, and Neoplastic TransformationPublished by Springer Nature ,1984
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957